# SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines

> **NCT06267924** · NA · COMPLETED · sponsor: **Otolith Labs** · enrollment: 322 (actual)

## Conditions studied

- Vestibular Migraine
- Migraine Associated Vertigo

## Interventions

- **DEVICE:** Otoband Experimental
- **DEVICE:** Otoband Sham

## Key facts

- **NCT ID:** NCT06267924
- **Lead sponsor:** Otolith Labs
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-06
- **Primary completion:** 2024-12-09
- **Final completion:** 2025-01-08
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06267924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06267924, "SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06267924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*